Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease

计划入组 460 人 · 首次发布于 2018 年 8 月 17 日

The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment

计划入组 175 人 · 首次发布于 2014 年 4 月 2 日

Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery Disease

计划入组 75 人 · 首次发布于 2020 年 10 月 12 日

miRNA-3157

miRNA-29

AGMB-129

Mirna Therapeutics, Inc.

United States

BioVersys AG

Switzerland

NTC SRL

Italy

Novel miRNA-129–Based Therapy Achieves Over 95% Tumor Shrinkage in Preclinical NSCLC Model, Halting Drug Resistance

Thalia Acquires Sanmirna, Secures £2.75M to Advance Anti-miRNA Therapy for AML

Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease